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Dear Editor,
Hereditary hemochromatosis (HH) is the most fre-
quent genetic disease in populations of European ori-
gin. The HH gene was cloned by Feder et al.  in 1996, and 
2 major mutations were discovered: C282Y and H63D. 
Geographical diﬀerences with mutation frequencies 
have been published (1, 2) with a decreasing gradient of 
occurrence in Europe from north to south.  HH leads to 
liver iron overload and raised liver iron concentration 
(LIC) is associated with liver ﬁbrosis. When the LIC reach-
es 60μmol/g, or approximately twice the upper limit of 
the normal range (36μmol/g), activation of stellate cells 
appears. These cells are principally responsible for the 
beginning of liver ﬁbrosis and ﬁbrosis (3). This process 
can lead to hepatic cirrhosis at the end stage. So it is of 
interest to ask ourselves, for those patients with cirrho-
sis but without any known culprit as the cause, whether 
iron surcharge and mutations of the HFE gene that may 
induce this iron overload could play a relevant role in the 
etiopathogenesis of cryptogenic cirrhosis. 
Jowkar et al. (4) have recently published a prospective 
study to investigate the probable association of HFE gene 
mutations in a group of 100 patients with cryptogenic 
cirrhosis and compared  the results with a control group 
of 50 normal, unrelated healthy individuals. No homo-
zygotes for C282Y and H63D mutations were found, and 
only 22% of the patients and 28% of controls (P > 0.05) 
were heterozygous for the H63D mutation. Most of the 
cirrhotic patients and controls with this mutation did 
not have liver iron overload. Few studies have investigat-
ed the frequency of HFE gene mutations in patients with 
chronic liver diseases and cirrhosis. The results from the 
Jowkar et al. (4) study are similar to those published from 
Indian and Turkish patients (5, 6). More recently, Sikorska 
et al. (7) studied iron overload and HFE gene mutations 
in Polish patients with liver cirrhosis (61 patients), and 
they were compared with a control group of 42 consecu-
tive patients subjected to liver biopsy because of chronic 
liver disease. They concluded that iron disorders are 
frequently detected in patients with liver cirrhosis, but 
without signiﬁcant association with HFE gene muta-
tions. Another recent study from India (8) tried to ﬁnd 
the association of common HFE mutations and primary 
iron overload in liver cirrhosis. Of the 496 patients (242 
cryptogenic cirrhosis) included in the study, only 13 had 
iron overload and only two were H63D heterozygous. The 
overall frequency of the H63D allele in patients and con-
trols was not signiﬁcantly diﬀerent (P < 0.17). 127
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Jowkar et al. (4), with their interesting study developed 
in Iran, seem to reinforce the theory that cryptogenic 
cirrhosis is not associated with iron overload, nor with 
major HFE mutations. It also appears that there are no 
geographical diﬀerences, since their results are similar 
to those published in Poland, Europe.
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